Associations Among Fatty Acids, Desaturase and Elongase, and Insulin Resistance in Children

References

• Fryar CD, Carroll MD, Ogden CL: “Prevalence of Overweight and Obesity Among Children and Adolescents Aged 2–19 Years: United States, 1963–1965 Through 2013–2014.” https://www.cdc.gov/nchs/data/hestat/obesity_child_13_14/obesity_child_13_14.pdf. Accessed November 14, 2016.
   Google Scholar
• Biro FM, Wien M: Childhood obesity and adult morbidities. The American Journal of Clinical Nutrition 91:1499S–1505S, 2010.
   PubMed Web of Science ®Google Scholar
• Weiss R, Caprio S: The metabolic consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab 19:405–419, 2005.
   PubMed Web of Science ®Google Scholar
• Zaqout M, Michels N, Bammann K, Ahrens W, Sprengeler O, Molnar D, Hadjigeorgiou C, Eiben G, Konstabel K, Russo P, Jimenez D, Moreno LA, and De Benauw S: Influence of physical fitness on cardio-metabolic risk factors in European children. Int J Obes (Lond) 40:119–125, 2016.
   Web of Science ®Google Scholar
• Sijtsma A, Bocca G, L'Abee C, Liem ET, Sauer PJJ, Corpeleijn E: Waist-to-height ratio, waist circumference and BMI as indicators of percentage fat mass and cardiometabolic risk factors in children aged 3–7 years. Clin Nutr 33:311–315, 2014.
   PubMed Web of Science ®Google Scholar
• Ma J, Folsom AR, Shahar E, Eckfeldt JH: Plasma fatty-acid composition as an indicator of habitual dietary-fat intake in middle-aged adults. American Journal of Clinical Nutrition 62:564–571, 1995.
   PubMed Web of Science ®Google Scholar
• Salo P, Viikari J, Hamalainen M, Lapinleimu H, Routi T, Niinikosk H, Rask-Nissila L, Tammi A, Ronnemaa T, Seppanen R, Jokinen E, Valimaki I, Simell O: Fatty acid composition of serum cholesterol esters as a reflector of low-saturated-fat, low-cholesterol diet in young children: the STRIP project. The Special Turku coronary Risk factor Intervention Project. Acta Paediatr 2000;89:399–405.
   Google Scholar
• Nakamura MT, Nara TY: Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annual Review of Nutrition 24:345–376, 2004.
   PubMed Web of Science ®Google Scholar
• Merino DM, Ma DW, Mutch DM: Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids in Health and Disease 9:63, 2010.
   PubMed Web of Science ®Google Scholar
• Saito E, Okada T, Abe Y, Kuromori Y, Miyashita M, Iwata F, Hara M, Ayusawa M, Mugishima H, Kitamura Y: Docosahexaenoic acid content in plasma phospholipids and desaturase indices in obese children. Journal of Atherosclerosis and Thrombosis 18:345–350, 2011.
   PubMed Web of Science ®Google Scholar
• Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C: Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. The American Journal of Clinical Nutrition 82:1178–1184, 2005.
   PubMed Web of Science ®Google Scholar
• Steffen LM, Vessby B, Jacobs Jr DR, Steinberger J, Moran A, Hong CP, Sinaiko AR: Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes (Lond) 32:1297–1304, 2008.
   PubMed Web of Science ®Google Scholar
• Okada T, Furuhashi N, Kuromori Y, Miyashita M, Iwata F, Harada K: Plasma palmitoleic acid content and obesity in children. The American Journal of Clinical Nutrition 82:747–750, 2005.
   PubMed Web of Science ®Google Scholar
• Warensjo E, Rosell M, Hellenius ML, Vessby B, De Faire U, Riserus U: Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids in Health and Disease 8:37, 2009.
   PubMed Web of Science ®Google Scholar
• Moon YA, Ochoa CR, Mitsche MA, Hammer RE, Horton JD: Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance. J Lipid Res 55:2597–2605, 2014.
   PubMed Web of Science ®Google Scholar
• Wolters M, Schlenz H, Bornhorst C, Rise P, Galli C, Moreno LA, Pala V, Siani A, Veidebaum T, Tornaritis M, Fraterman A, de Henauw S, Marild S, Molnar D, Ahrens W: Desaturase activity is associated with weight status and metabolic risk markers in young children. The Journal of Clinical Endocrinology and Metabolism 100:3760–3769, 2015.
   PubMed Web of Science ®Google Scholar
• Choi YS, Jang HB, Park JY, Lee HJ, Kang JH, Park KH, L JH, Park SI, Song J: Associations between estimated desaturase activity and insulin resistance in Korean boys. Osong Public Health and Research Perspectives 5:251–257, 2014.
   PubMedGoogle Scholar
• Saito E, Okada T, Abe Y, Odaka M, Kuromori Y, Iwata F, Hara M, Mugishima H, Kitamura Y: Abdominal adiposity is associated with fatty acid desaturase activity in boys: implications for C-reactive protein and insulin resistance. Prostaglandins, Leukotrienes, and Essential Fatty Acids 88:307–311, 2013.
   PubMed Web of Science ®Google Scholar
• Zhou YE, Egeland GM, Meltzer SJ, Kubow S: The association of desaturase 9 and plasma fatty acid composition with insulin resistance-associated factors in female adolescents. Metabolism: Clinical and Experimental 58:158–166, 2009.
   PubMed Web of Science ®Google Scholar
• Matsuzaka T, Shimano H: Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med (Berl) 87:379–384, 2009.
   PubMed Web of Science ®Google Scholar
• Yew Tan C, Virtue S, Murfitt S, Robert LD, Phua YH, Dale M, Griffin JL, Tinahones F, Scherer PE, Vidal-Puig A: Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance. Sci Rep 5:18366, 2015.
   PubMed Web of Science ®Google Scholar
• Scherr RE, Linnell JD, Dharmar M, Beccarelli LM, Bergman JJ, Briggs M, Brian KM, Feenstra G, Hillhouse JC, Keen CL, Ontai LL, Schaefer SE, Smith MH, Spezzano T, Steinberg FM, Sutter C, Young HM, Zidenberg-Cherr S. A multicomponent, school-based intervention, the Shaping Healthy Choices Program, improves nutrition-related outcomes. J Nutr Ed Behav 49:368–379, 2017.
   PubMed Web of Science ®Google Scholar
• Barlow SE: Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120:S164–S192, 2007.
   PubMed Web of Science ®Google Scholar
• Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: 2000 CDC growth charts for the United States: methods and development. Vital and Health Statistics Series 11:1–190, 2002.
   Google Scholar
• Prevention CDC: Defining Childhood Obesity. Centers for Disease Control and Prevention. http://www.cdc.gov/obesity/childhood/defining.html. Accessed December 9, 2016.
   Google Scholar
• Smedes F: Determination of total lipid using non-chlorinated solvents. Analyst 124:1711–1718, 1999.
   Web of Science ®Google Scholar
• Gladine C, Newman JW, Durand T, Pedersen TL, Galano JM, Demougeot C, Berdeaux O, Pujos-Guillot E, Mazur A, Comte B: Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention. PLoS One 9:e89393, 2014.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang T, Li S, Li Y, Hussain A, Fernandez C, Harville E, Bazzano LA, He J, Chen W: Long-term impact of childhood adiposity on adult metabolic syndrome is modified by insulin resistance: the Bogalusa Heart Study. Sci Rep 5:17885, 2015.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhang H, Li S, Li Y, Liu Y, Fernandez C, Harville E, Bazzano LA, He J, Chen W: Impact of adiposity on incident hypertension is modified by insulin resistance in adults: Longitudinal observation from the Bogalusa Heart Study. Hypertension 67:56–62, 2016.
   PubMed Web of Science ®Google Scholar
• Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F, Sesti G: Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 30:2145–2147, 2007.
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Abbasi F, Lamendola C, Reaven G: Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 167:642–648, 2007.
   PubMedGoogle Scholar
• Vukovic R, Mitrovic K, Milenkovic T, Todorovic S, Soldatovic I, Sipetic-Grujicic S, Zdravkovic D: Insulin-sensitive obese children display a favorable metabolic profile. Eur J Pediatr 172:201–206, 2013.
   PubMed Web of Science ®Google Scholar
• Messiah SE, Arheart KL, Natale RA, Hlaing WM, Lipshultz SE, Miller TL: BMI, waist circumference, and selected cardiovascular disease risk factors among preschool-age children. Obesity 20:1942–1949, 2012.
   PubMed Web of Science ®Google Scholar
• Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering – Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168:1617–1624, 2008.
   PubMed Web of Science ®Google Scholar
• Gutierrez-Repiso C, Soriguer F, Rojo-Martinez G, Garcia-Fuentes E, Valdes S, Goday A, Calle-Pascual A, Lopez-Alba A, Castell C, Menendez E, Bordiu E, Delgado E, Ortega E, Pascual-Manich G, Urrutia I, Mora-Peces I, Vendrell J, Vazquez JA, Franch J, Girbes J, Castano L, Serrano-Rios M, Martinez-Larrad MT, Catala M, Carmena R, Gomis R, Casamitjana R, Gaztambide S: Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the [email protected] study. Nutrition, Metabolism, and Cardiovascular Diseases 24:947–955, 2014.
   PubMed Web of Science ®Google Scholar
• Boonchaya-anant P, Apovian CM: Metabolically healthy obesity–does it exist? Curr Atheroscler Rep 16:441, 2014.
   PubMed Web of Science ®Google Scholar
• Bervoets L, Massa G: Classification and clinical characterization of metabolically “healthy” obese children and adolescents. J Pediatr Endocrinol Metab 29:553–560, 2016.
   PubMed Web of Science ®Google Scholar
• Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GD: Predictors of metabolically healthy obesity in children. Diabetes Care 37:1462–1468, 2014.
   PubMed Web of Science ®Google Scholar
• Dai S, Yang Q, Yuan K, Loustalot F, Fang J, Daniels SR, Hong Y: Non-high-density lipoprotein cholesterol: distribution and prevalence of high serum levels in children and adolescents: United States National Health and Nutrition Examination Surveys, 2005–2010. J Pediatr 164:247–253, 2014.
   PubMed Web of Science ®Google Scholar
• Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL: Distributions and trends of serum lipid levels among United States children and adolescents ages 4–19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879–890, 1998.
   PubMed Web of Science ®Google Scholar
• Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C: Trends in serum lipids among US youths aged 6 to 19 years, 1988–2010. JAMA 308:591–600, 2012.
   PubMed Web of Science ®Google Scholar
• Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A: Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967:183–195, 2002.
   PubMed Web of Science ®Google Scholar
• Venäläinen T, Agren J, Schwab U, de Mello VD, Eloranta AM, Laaksonen DE, Lindi V, Lakka TA: Cross-sectional associations of plasma fatty acid composition and estimated desaturase and elongase activities with cardiometabolic risk in Finnish children–The PANIC study. J Clin Lipidol 10:82–91, 2016.
   PubMed Web of Science ®Google Scholar
• Warensjo E, Riserus U, Vessby B: Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48:1999–2005, 2005.
   PubMed Web of Science ®Google Scholar
• Pan DA, Hulbert AJ, Storlien LH: Dietary fats, membrane phospholipids and obesity. The Journal of Nutrition 124:1555–1565, 1994.
   PubMed Web of Science ®Google Scholar
• Pan DA, Lillioja S, Milner MR, Kriketos AD, Baur LA, Bogardus C, Storlien LH: Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96:2802–2808, 1995.
   PubMed Web of Science ®Google Scholar
• Mooradian AD: Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150–159, 2009.
   PubMedGoogle Scholar
• Jacobs S, Schiller K, Jansen EH, Boeing H, Schulze MB, Kroger J: Evaluation of various biomarkers as potential mediators of the association between Delta5 desaturase, Delta6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. The American Journal of Clinical Nutrition 102:155–164, 2015.
   PubMed Web of Science ®Google Scholar
• Kurtoglu S, Hatipoglu N, Mazicioglu M, Kendirici M, Keskin M, Kondolot M: Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol 2:100–106, 2010.
   PubMedGoogle Scholar
• Singh Y, Garg MK, Tandon N, Marwaha RK: A study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents. J Clin Res Pediatr Endocrinol 5:245–251, 2013.
   PubMed Web of Science ®Google Scholar
• Guzzaloni G, Grugni G, Mazzilli G, Moro D, Morabito F: Comparison between beta-cell function and insulin resistance indexes in prepubertal and pubertal obese children. Metabolism: Clinical and Experimental 51:1011–1016, 2002.
   PubMed Web of Science ®Google Scholar
• Tobisch B, Blatniczky L, Barkai L: Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty. Pediatr Obes 10:37–44, 2015.
   PubMed Web of Science ®Google Scholar